The number of people with susceptibility test result for rifampicin in Equatorial Guinea
Equatorial Guinea: The number of people with susceptibility test result for rifampicin was 492 in 2021. ◆ Volatile
Latest (2021)
492
Change on year
up 96.8%
World rank
80th
of 155 countries
All-time high
492
in 2021
All-time low
2
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Equatorial Guinea, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Equatorial Guinea recorded 492 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 96.8% on the previous year and up 24,500.0% over five years.
That places Equatorial Guinea 80th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Equatorial Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 2 | — |
| 2018 | 58 | +2800.0% |
| 2019 | 34 | -41.4% |
| 2020 | 250 | +635.3% |
| 2021 | 492 | +96.8% |
Equatorial Guinea compared with similar countries
- Equatorial Guinea's 492 is below the median for upper middle income countries, which is 880, 56% of the median. (46 countries reporting)
- Equatorial Guinea's 492 is below the median for Sub-Saharan Africa, which is 2,015, 24% of the median. (33 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 31.33 | 2 | 58 | 3 |
| 2020s | 371 | 250 | 492 | 2 |
Countries ranked near Equatorial Guinea
More health data for Equatorial Guinea
- Un projection of annual infant deaths, annual growth rate -1.4 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.06 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 863.6 deaths per 1,000 people (2090)
- Number of infants who die before age 1 843 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 5 (2025)
- Population ages 00-04, female, annual growth rate 1.5 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0663 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.66 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Equatorial Guinea?
- The number of people with susceptibility test result for rifampicin in Equatorial Guinea was 492 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Equatorial Guinea?
- The highest recorded value was 492 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Equatorial Guinea?
- The lowest recorded value was 2 in 2017.
- How does Equatorial Guinea rank for the number of people with susceptibility test result for rifampicin?
- Equatorial Guinea ranks 80th out of 155 countries with data for 2021.
- Where does this Equatorial Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).